Many people in the world know only too well. Asthma affects an estimated 339 million people and causes 417,000 deaths a year, or over 1,000 per day. In low-income countries, asthma drugs are often either unaffordable or unavailable. Watch a YouTube video of our work here.
We provide essential asthma medication to children and adults in low-income countries, where access to treatment is often limited. We have established a successful project in Vietnam and are currently planning a project in Kenya.
Asthma is the most common chronic disease in children and adolescents globally. Supplying medication for asthma enables children and adults to lead healthy, productive lives and take charge of their societies.
We provide regular updates on how donations are being used. We offer donors the chance to ring-fence their donations so that 100% goes towards any chosen aspect of the work we do. Our projects are costed over the long term.
In the West we take effective asthma medication for granted. But in low-income countries asthma often goes uncontrolled.
At Asthma International we focus on children. According to the World Health Organization, asthma is the most common chronic disease in children and adolescents globally. In terms of numbers of sufferers, it ranks far ahead of diseases such as diabetes, cancer and HIV. Children with asthma may be unable to attend school. They may be unable to run and play. Their lung development may be curtailed so that they cannot lead healthy lives as adults or earn a living. Asthma has the power to blight lives – and to kill, at the rate of well over 1,000 people per day.
The World Health Organization succinctly states that "in children with asthma, poverty aggravates asthma and asthma aggravates poverty.”
This is the situation that Asthma International seeks to redress.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.